NCT06918704 · RECRUITING

BID WM Digital Intervention in Aging

This trial is testing two digital brain-training apps — called Coherence and Worder — to see whether eight weeks of at-home use can improve working memory and inhibitory control in older adults, including those with mild cognitive impairment. It is a Phase NA study, meaning this is more of a feasibility and efficacy exploration than a late-stage drug trial. Participants do everything remotely, with check-ins at baseline, post-intervention, and six months later.

You may qualify if

  • Minimum of 12 years of education
  • English fluency
  • Normal or corrected-to-normal vision
  • Normal or corrected-to-normal vision
  • Medically healthy older adults including those with below-average cognitive performance or mild cognitive impairment patients without dementia

You're excluded if

  • Under the age of 60
  • Clinical diagnosis of neurological or psychiatric disorder
  • Visually or hearing impaired without correction to normal
  • Clinical diagnosis of dementia or AD8 score of >3
  • Regularly (one or more times per week) practicing an instrument within the last year
  • 10 or more years of formal musical instrument training

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-04-01

View full record on ClinicalTrials.gov

All APOE4 clinical trials